44:90:09:01Mandatory testing prior to transfer for retail sale.

A medical cannabis establishment must test every batch of cannabis or cannabis product intended for retail sale in final form prior to transfer. Any alterations made by a medical cannabis establishment after receipt of cannabis or cannabis product results in the creation of a new final form. The following tests are required for cannabis and cannabis products: (1) Potency for tetrahydrocannabinol (THC) content and, if so labeled, cannabidiol content. The allowed variance for THC content may not exceed plus or minus ten percent; (2) Microbials listed in subdivision 44:90:05:10(3); (3) Mycotoxins listed in subdivision 44:90:05:10(2); (4) Metals listed in subdivision 44:90:05:10(4) and § 44:90:07:03; (5) Pesticides listed in subdivision 44:90:05:10(1); and (6) Solvents listed in § 44:90:07:03.

Source: 48 SDR 40, effective October 5, 2021; 49 SDR 9, effective August 8, 2022; 50 SDR 62, effective November 27, 2023.